(VIANEWS) – The NASDAQ ended the session with Merrimack Pharmaceuticals rising 8.97% to $5.10 on Thursday, after two sequential sessions in a row of gains. NASDAQ Composite rose 1.73% to $14,823.43, following the last session’s upward trend on what was an all-around up trend trading session today.
Today’s last reported volume for Merrimack Pharmaceuticals is 23082, 11.12% above its average volume of 20772.
Merrimack Pharmaceuticals’s last close was $4.68, 50.48% below its 52-week high of $9.45.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Merrimack Pharmaceuticals’s stock is considered to be oversold (<=20).
Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value
Merrimack Pharmaceuticals’s stock is valued at $5.10 at 17:20 EST, way under its 52-week high of $9.45 and way higher than its 52-week low of $3.56.
Merrimack Pharmaceuticals’s Moving Average
Merrimack Pharmaceuticals’s worth is way above its 50-day moving average of $4.61 and way under its 200-day moving average of $5.83.
More news about Merrimack Pharmaceuticals (MACK).